Metraipolis › archive › dc_80eb581e658e

Myelodysplastic Syndrome Secondary to Chimeric Antigen Receptor T-cell (CAR-T) Therapy for the Treatment of Relapsed/Refractory Multiple Myeloma — Europe PMC PMID:41859580

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41859580
DOI
10.7759/cureus.103706
License (as archived)
solo-consultazione
Archived
2026-11-05T18:58:35.519Z
SHA-256 of the archived text
7d307edbc13bd05c51c0c987418e9206a625eead4ef22f32d89a70caf2e26b7e
Stable URL of this page
https://metraipolis.com/documento/dc_80eb581e658e

How to cite

Myelodysplastic Syndrome Secondary to Chimeric Antigen Receptor T-cell (CAR-T) Therapy for the Treatment of Relapsed/Refractory Multiple Myeloma — Europe PMC PMID:41859580 — Europe PMC (en), https://europepmc.org/article/MED/41859580 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_80eb581e658e (Metraipolis archive dc_80eb581e658e, sha256 7d307edbc13bd05c51c0c987418e9206a625eead4ef22f32d89a70caf2e26b7e)
BibTeX
@misc{dc80eb581e658e,
  title = {Myelodysplastic Syndrome Secondary to Chimeric Antigen Receptor T-cell (CAR-T) Therapy for the Treatment of Relapsed/Refractory Multiple Myeloma — Europe PMC PMID:41859580},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41859580},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_80eb581e658e; sha256 7d307edbc13bd05c51c0c987418e9206a625eead4ef22f32d89a70caf2e26b7e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41859580. Agents can read the archived copy with the MCP tool read_document.